5 research outputs found
EcoFlex: A Multifunctional MoClo Kit for E. coli Synthetic Biology
Golden Gate cloning is a prominent DNA assembly tool in synthetic biology for the assembly of plasmid constructs often used in combinatorial pathway optimisation, with a number of assembly kits developed specifically for yeast and plant-based expression. However, its use for synthetic biology in commonly used bacterial systems such as Escherichia coli, has surprisingly been overlooked. Here, we introduce EcoFlex a simplified modular package of DNA parts for a variety of applications in E. coli, cell-free protein synthesis, protein purification and hierarchical assembly of transcription units based on the MoClo assembly standard. The kit features a library of constitutive promoters, T7 expression, RBS strength variants, synthetic terminators, protein purification tags and fluorescence proteins. We validate EcoFlex by assembling a 68-part containing (20 genes) plasmid (31 kb), characterise in vivo and in vitro library parts, and perform combinatorial pathway assembly, using pooled libraries of either fluorescent proteins or the biosynthetic genes for the antimicrobial pigment violacein as a proof-of-concept. To minimise pathway screening, we also introduce a secondary module design site to simplify MoClo pathway optimisation. In summary, EcoFlex provides a standardised and multifunctional kit for a variety of applications in E. coli synthetic biology
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) enzymes are secreted, multi-domain matrix-associated zinc metalloendopeptidases that have diverse roles in tissue morphogenesis and patho-physiological remodeling, in inflammation and in vascular biology. The human family includes 19 members that can be sub-grouped on the basis of their known substrates, namely the aggrecanases or proteoglycanases (ADAMTS1, 4, 5, 8, 9, 15 and 20), the procollagen N-propeptidases (ADAMTS2, 3 and 14), the cartilage oligomeric matrix protein-cleaving enzymes (ADAMTS7 and 12), the von-Willebrand Factor proteinase (ADAMTS13) and a group of orphan enzymes (ADAMTS6, 10, 16, 17, 18 and 19). Control of the structure and function of the extracellular matrix (ECM) is a central theme of the biology of the ADAMTS, as exemplified by the actions of the procollagen-N-propeptidases in collagen fibril assembly and of the aggrecanases in the cleavage or modification of ECM proteoglycans. Defects in certain family members give rise to inherited genetic disorders, while the aberrant expression or function of others is associated with arthritis, cancer and cardiovascular disease. In particular, ADAMTS4 and 5 have emerged as therapeutic targets in arthritis. Multiple ADAMTSs from different sub-groupings exert either positive or negative effects on tumorigenesis and metastasis, with both metalloproteinase-dependent and -independent actions known to occur. The basic ADAMTS structure comprises a metalloproteinase catalytic domain and a carboxy-terminal ancillary domain, the latter determining substrate specificity and the localization of the protease and its interaction partners; ancillary domains probably also have independent biological functions. Focusing primarily on the aggrecanases and proteoglycanases, this review provides a perspective on the evolution of the ADAMTS family, their links with developmental and disease mechanisms, and key questions for the future
Opportunities to accelerate extracellular vesicle research with cellāfree synthetic biology
Abstract Extracellular vesicles (EVs) are lipidāmembrane nanoparticles that are shed or secreted by many different cell types. The EV research community has rapidly expanded in recent years and is leading efforts to deepen our understanding of EV biological functions in human physiology and pathology. These insights are also providing a foundation on which future EVābased diagnostics and therapeutics are poised to positively impact human health. However, current limitations in our understanding of EV heterogeneity, cargo loading mechanisms and the nascent development of EV metrology are all areas that have been identified as important scientific challenges. The field of synthetic biology is also contending with the challenge of understanding biological complexity as it seeks to combine multidisciplinary scientific knowledge with engineering principles, to build useful and robust biotechnologies in a responsible manner. Within this context, cellāfree systems have emerged as a powerful suite of in vitro biotechnologies that can be employed to interrogate fundamental biological mechanisms, including the study of aspects of EV biogenesis, or to act as a platform technology for medical biosensors and therapeutic biomanufacturing. Cellāfree gene expression (CFE) systems also enable in vitro protein production, including membrane proteins, and could conceivably be exploited to rationally engineer, or manufacture, EVs loaded with bespoke molecular cargoes for use in foundational or translational EV research. Our pilot data herein, also demonstrates the feasibility of cellāfree EV engineering. In this perspective, we discuss the opportunities and challenges for accelerating EV research and healthcare applications with cellāfree synthetic biology
EcoFlex: A Multifunctional MoClo Kit for <i>E.Ā coli</i> Synthetic Biology
Golden Gate cloning is a prominent
DNA assembly tool in synthetic
biology for the assembly of plasmid constructs often used in combinatorial
pathway optimization, with a number of assembly kits developed specifically
for yeast and plant-based expression. However, its use for synthetic
biology in commonly used bacterial systems such as <i>Escherichia
coli</i> has surprisingly been overlooked. Here, we introduce
EcoFlex a simplified modular package of DNA parts for a variety of
applications in <i>E.Ā coli</i>, cell-free protein synthesis,
protein purification and hierarchical assembly of transcription units
based on the MoClo assembly standard. The kit features a library of
constitutive promoters, T7 expression, RBS strength variants, synthetic
terminators, protein purification tags and fluorescence proteins.
We validate EcoFlex by assembling a 68-part containing (20 genes)
plasmid (31 kb), characterize <i>in vivo</i> and <i>in vitro</i> library parts, and perform combinatorial pathway
assembly, using pooled libraries of either fluorescent proteins or
the biosynthetic genes for the antimicrobial pigment violacein as
a proof-of-concept. To minimize pathway screening, we also introduce
a secondary module design site to simplify MoClo pathway optimization.
In summary, EcoFlex provides a standardized and multifunctional kit
for a variety of applications in <i>E.Ā coli</i> synthetic
biology